http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002107281-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_921b7d8f18db5057558b7ef64c3d10ad |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate | 2001-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f087938073f6452e463752b6230ed14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f36338cfa1803a1d315ccfb4c8bcdd17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662f237de7320f2a4283d6eca984a1cc |
| publicationDate | 2002-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002107281-A1 |
| titleOfInvention | Phototherapeutic and chemotherapeutic immunotherapy against tumors |
| abstract | The present invention is directed to new methods, medicaments and pharmaceutical compositions and agents for improved cancer treatment that lower recurrence of the primary tumor by causing selective, acute destruction of tumor tissue and thereby exposing the immune system to large amounts of substantially non-denatured tumor material over a short period of time. This effectively vaccinates the host against tumor tissue, allowing the host's immune system to attack any residual tumor tissue, and thereby reduces the recurrence rate and metastasis to remote sites. In preferred embodiments, this enhancement is achieved through application of phototherapeutic or chemotherapeutic modalities that are capable of producing such an acute, necrotic effect on treated lesions without completely denaturing tumor antigens. |
| priorityDate | 2000-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.